Precigen to Participate in a Virtual Fireside Chat at Cantor’s “The Future of Oncology” Virtual Symposium

GERMANTOWN, Md., March 28, 2023 /PRNewswire/ — Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced Helen Sabzevari, PhD, President and CEO of Precigen, will…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.